- Home
- ORIQ vs ALGS Comparison
ORIQ vs ALGS Comparison
Compare ORIQ & ALGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORIQ
- ALGS
- Stock Information
- Founded
- ORIQ 2024
- ALGS 2018
- Country
- ORIQ Singapore
- ALGS United States
- Employees
- ORIQ N/A
- ALGS N/A
- Industry
- ORIQ
- ALGS Biotechnology: Pharmaceutical Preparations
- Sector
- ORIQ
- ALGS Health Care
- Exchange
- ORIQ Nasdaq
- ALGS Nasdaq
- Market Cap
- ORIQ 87.2M
- ALGS 72.6M
- IPO Year
- ORIQ 2025
- ALGS 2020
- Fundamental
- Price
- ORIQ $10.10
- ALGS $9.32
- Analyst Decision
- ORIQ
- ALGS Strong Buy
- Analyst Count
- ORIQ 0
- ALGS 2
- Target Price
- ORIQ N/A
- ALGS $60.00
- AVG Volume (30 Days)
- ORIQ 23.4K
- ALGS 97.2K
- Earning Date
- ORIQ 01-01-0001
- ALGS 11-06-2025
- Dividend Yield
- ORIQ N/A
- ALGS N/A
- EPS Growth
- ORIQ N/A
- ALGS N/A
- EPS
- ORIQ N/A
- ALGS N/A
- Revenue
- ORIQ N/A
- ALGS $3,174,000.00
- Revenue This Year
- ORIQ N/A
- ALGS N/A
- Revenue Next Year
- ORIQ N/A
- ALGS N/A
- P/E Ratio
- ORIQ N/A
- ALGS N/A
- Revenue Growth
- ORIQ N/A
- ALGS N/A
- 52 Week Low
- ORIQ $9.98
- ALGS $3.76
- 52 Week High
- ORIQ $10.12
- ALGS $46.80
- Technical
- Relative Strength Index (RSI)
- ORIQ N/A
- ALGS 43.57
- Support Level
- ORIQ N/A
- ALGS $9.25
- Resistance Level
- ORIQ N/A
- ALGS $10.89
- Average True Range (ATR)
- ORIQ 0.00
- ALGS 0.79
- MACD
- ORIQ 0.00
- ALGS -0.07
- Stochastic Oscillator
- ORIQ 0.00
- ALGS 13.76
About ORIQ Origin Investment Corp I Ordinary Shares
Origin Investment Corp I is a blank check company.
About ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.